Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
BÜHLMANN Laboratories AG Announces New Health Canada Licences for Quantum Blue® Infliximab Assay, IBDoc®, and CALEX® Cap Device
BÜHLMANN Laboratories AG’s Quantum Blue® Infliximab, lateral flow assay for rapid quantification of Infliximab in Serum; IBDoc®, the first in-vitro diagnostic home testing device measuring the inflammatory marker fecal calprotectin at home; as well as CALEX® Cap Device for rapid stool extraction are now commercially available in Canada and are Health Canada licenced. - May 02, 2017 - BUHLMANN Diagnostics Corp
Prescribe with Confidence. GenoScribe Live Software by Emgenex is Integrating Pharmacogenetic Testing with Medication Risk Management Software
GenoScribe by Emgenex is an extensive and unprecedented pharmacogenetic testing service to help providers personalize treatment and medications based on a patient's genetics. Now the offering of GenoScribe Live software is going beyond pharmacogenetics. It is a comprehensive medication risk management tool powered by data, analytics and scientific research. - May 02, 2017 - Emgenex
Top Low Dose Naltrexone Practitioners to Speak at LDN Research Trust’s 4th AIIC LDN Conference in Portland, Oregon, USA
The LDN 2017 conference and expo will be held September 21-24, 2017, Sheraton Airport Hotel, Portland, Oregon. This unique event will feature the latest information from a panel of 29 researchers and health care providers, on topics ranging from practical advice about the dosing and biological action of LDN, to the latest research on and experience with the use of LDN to treat a wide variety of conditions. Admission to the conference includes online access to bonus case studies. - May 01, 2017 - LDN Research Trust
12 Months on: European Commission Present Updates on GDPR Timelines and Objectives at 7th Annual Biobanking Industry Summit
Legal advisor and policy analyst to provide opening keynote on the Impact of the General Data Protection Regulation (GDPR) on collaborative science in Europe. - April 29, 2017 - SAE Media Group
Smart Insulin Pens Market Poised for Robust CAGR of Over 17.9% Through 2027
Future Market Insights has announced the addition of the "Smart Insulin Pens Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering. - April 29, 2017 - Future Market Insights
New Research Identifies Need for Patient-Centric Clinical Trials and Role for CROs
New Research Identifies Patient-centric Strategies for Clinical Development with over 125 Global Research Opinion Leaders. - April 28, 2017 - Life Science Strategy Group, LLC
Clear Sky Recovery's Ibogaine Treatment Program to be Featured on National Geographic
“Addiction: A Psychedelic Cure?” will air on the National Geographic Channel on Tuesday, May 2 at 10 p.m. ET/9 p.m. CT. - April 28, 2017 - Clear Sky Recovery
ClinLab Staffing Named to the 2017 FAST 50 List
ClinLab Staffing, a leading staffing and recruiting firm for life science, pharmaceutical, biotechnology and preclinical organizations, today announced that it has been named to the Boston Business Journal’s 2017 FAST 50 List of Top Fastest Growing Private Companies in Massachusetts for the... - April 27, 2017 - ClinLab Staffing
New Non-Profit Launches to Help Stop the Heroin Epidemic
SeekHealing to commence fundraising at launch party in Washington, DC, to offer post-detox rehabilitation programs in mid-Atlantic region. - April 26, 2017 - SeekHealing
New Microplate-Based Method to Measure OCR and ECA Under Steady-State [O2]
Cayman Chemical, in collaboration with BMG LABTECH GmbH, has developed a novel assay kit to measure mitochondrial function under a dynamic range of oxygen concentrations. The Mito Stress Test (ACU Format) is designed to measure oxygen consumption rate (OCR) and extracellular acidification (ECA)... - April 26, 2017 - Cayman Chemical Company
PathogenDx, Inc. Launches Disruptive Environmental Screening Technology for Growers and Cultivators in the Legalized Cannabis Sector
PathogenDx, an Arizona based biotechnology company, which has developed a disruptive, game-changing pathogen detection screening platform recently completed the development of its second product as an entre into the legalized cannabis sector. The PDx-Es technology for Environmental Screening will provide growers and cultivators information on detection of pathogen contamination for up to 30 organisms within less than a days turnaround of the test. - April 19, 2017 - PathogenDx
Cold, Cough and Sore Throat Remedies Market Expected to be Worth US$ 45.4 Bn by 2026
Future Market Insights has announced the addition of the “Cold, Cough and Sore Throat Remedies Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering. - April 06, 2017 - Future Market Insights
Another Agmatine Patent for Gilad&Gilad
The US Patent and Trademark Office (USPTO) has granted Gilad&Gilad an additional patent for agmatine use in dietary supplements, nutraceuticals, and foods. - April 04, 2017 - Gilad&Gilad
Axcel International Submits Corporate Partnership with Searching For The Cure Foundation
This non-monetary partnership insures a solid infrastructure for the various cancer patient programs, cannabis cancer research, and services currently in development. - March 31, 2017 - Searching For The Cure Foundation
Expert Evaluates Omega-3 DHA to EPA Ratio Controversy Using Algae Oil Models
Source-Omega Chief Scientific Officer and algae omega-3 expert, Dr. Scott Doughman, PhD, today answered frequently asked questions about the so-called DHA to EPA ratio controversy. Using past and present algae oil models, the case is presented in the form of a discussion, based on actual questions... - March 23, 2017 - Source-Omega
Alfa Scientific Designs, Inc., Pledges to Reach 80% Screened for Colorectal Cancer
Company joins the National Colorectal Cancer Roundtable to meet goal by 2018. - March 21, 2017 - Alfa Scientific Designs
Just Published Scientific Paper Shows Positive Results of Neurofeedback to Reduce Symptoms of Anxiety and Depression
“Combined Neurofeedback and Heart Rate Variability Training for Individuals with Symptoms of Anxiety and Depression; A Retrospective Study,” was published by a team of medical and psychological researchers led by Elyse K. White, Ph.D., of the brain performance company Neurocore. - March 16, 2017 - Neurocore LLC
Medicortex Finland Oy Receives an Innovation Grant for the Development of a Rapid Diagnostic Test for Traumatic Brain Injury
Medicortex Finland Oy received an innovation grant of €15,000 from the Finnish Runar Bäckström Foundation (Runar Bäckströmin säätiö), a foundation that supports innovation activities to help Finnish companies establish their positions within the international... - March 04, 2017 - Medicortex Finland Oy
Global Medical Education Publishing Market Analysis: Electronic Media, Print Media, Growth Trends and Forecast to 2020, New Report by iHealthcareAnalyst, Inc.
Medical Education Publishing Market by Electronic Media Publishing (Digital Textbooks and Reference Books, Distance Learning, Hospital Training, Mobile Applications, Multimedia Content, Online Reference Tools, Testing and Self-Assessment), Print Media Publishing (Custom Content, Distance Learning, Hospital Training, Print Textbooks and Reference Books, Testing and Self-Assessment) 2016-2020 - February 23, 2017 - iHealthcareAnalyst, Inc.
Kemwell Announces Successful USFDA Inspection at Bangalore Facility
Kemwell Biopharma, a global bio/pharmaceutical contract development and manufacturing company, announced today that its oral solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection. The inspection confirmed the... - February 19, 2017 - Kemwell Biopharma Private Limited
South Nassau Communities Hospital Names, Dedicates Medical Library in Honor of Former Medical Staff President
Dr. Singh joined South Nassau in 1977, and from that year onward he was a dependable, wise source of leadership, demonstrating a zeal for medical innovation centered on patient-centered care. - February 17, 2017 - Mount Sinai South Nassau
Virun® Releases STATIC™ Episode 2 While Under the Influence of Sulfur Hexaflouride, and New Probiotic Technology Makes Wholefoods Take Notice
Virun® NutraBiosciences® Ongoing Video Series Explores the Smells of Stability and Voice-changing Gases; Virun’s Patent & Patents-pending Non-refrigerated Shelf-stable Probiotics Become Available to Manufacturers Worldwide - February 14, 2017 - VIRUN
The 2017 Women in Oncology Award Winners Honored by PRIMO Education
The winners of the 2017 Women in Oncology Award were announced this morning at the 2nd Annual Practical Recommendations in Immuno and Molecular Oncology (PRIMO) Meeting. The Women in Oncology Awards are presented annually to three outstanding women in academia, industry, and advocacy, and seeks to recognize women who have made outstanding contributions to the lives of those fighting cancer. - February 13, 2017 - Cancer Expert Now, Inc.
Central Data Storage Announces the Release of Its Latest Version of UnisonBDR for Managed Backup and Disaster Recovery
Central Data Storage, one of the largest managed backup and disaster recovery companies in the United States, CDS helps clients avoid paying costly ransomware fees to criminal hackers holding their data and computer systems hostage. - February 07, 2017 - Central Data Storage
Big Pharma Perspective on Adaptive Clinical Trial Designs
Boehringer-Ingelheim, Grünenthal and AstraZeneca to discuss company approach to applied clinical trials. - January 19, 2017 - SAE Media Group
G&L Scientific Inc. Announces Opening of New Offices in Cambridge, Massachusetts
G&L Scientific Inc, the leading provider of clinical and scientific consulting and resource to the healthcare industry (http://www.gandlscientific.com), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and improving access to its expanding team of clinical and scientific consultants and contractors. This is the latest step in G&L’s expansion of its global clinical consulting services throughout the United States. - January 19, 2017 - G&L Scientific Inc
Dr. Shekhar Challa Joins Bioscience Americas Board of Advisors
Co-Founder of the Kansas Medical Clinic is a renowned gastroenterologist. - January 13, 2017 - Bioscience Americas
The Morgan Leary Vaughan Fund Launches First Natural History Registry for Necrotizing Enterocolitis
The Morgan Leary Vaughan Fund (Morgan's Fund) has launched the first natural history registry for Necrotizing Enterocolitis. The research study is open to participants worldwide to advance understanding and treatments for rare disease that leads to necrosis (death) of the intestine. - January 09, 2017 - The Morgan Leary Vaughan Fund, Inc.
VA Researchers Discover a Natural Antibody Potentially Capable of Preventing HIV Infection
A study of HIV conducted by researchers at VA Northern California Health Care System in Martinez, California showed that greater than 86 percent of uninfected adults have antibodies with characteristics potentially capable of protecting them against HIV infection. The results of the study appeared... - January 09, 2017 - Department of Veterans Affairs
Bioscience Americas Names Addition to Its Board of Advisors
Dr. Firas M. Kara joins Board to assist with Bioscience Americas international development efforts. - January 03, 2017 - Bioscience Americas
Dr. Dana Carroll to Deliver Keynote on Challenges in Programmable Genome Editing in San Diego
2nd Annual Genome Editing & Engineering Conference to be held on 6th - 7th February 2017 in San Diego, CA will see participation from global experts from pharmaceutical, bio-pharmaceutical companies, universities and academic institutions. The conference will look into various genome editing tools like CRISPR/Cas9 and TALENs and the potential they hold in developing biomedical and therapeutic applications. - December 30, 2016 - MarketsandMarkets
AABC Receives Approval by National Board for Certified Counselors
The American Association of Bariatric Counselors, Providers of Bariatric Education and Certification for Licensed, Registered and Certified Health and Education Professionals Has Become a Continuing Education Approved Provider for the National Board for Certified Counselors (NBCC). - December 21, 2016 - American Association of Bariatric Counselors
3D Map of PC2 to Jump-Start Drug Discovery Efforts in Polycystic Kidney Disease
Scientists from the Structural Genomics Consortium (SGC) and Oxford University report a three-dimensional view of the Polycystin-2 (PC2), a protein that causes autosomal dominant polycystic kidney disease (ADPKD) when mutated, in an article published this week in Nature Structural and Molecular... - December 21, 2016 - The SGC
Bioprognos Obtains the CE Marking for Its Algorithm to Support the Diagnostic of Lung Cancer
Bioprognos obtains the CE Declaration of Conformity for its algorithm to support the diagnostic of lung cancer after complying with the requirements of the European directive on medical devices and implementing a quality management system according to the standard UNE-EN ISO 13485:2016. - December 19, 2016 - Bioprognos SL
Fierce Innovation Awards: Life Sciences Edition Announce Finalists, Innovative Biochips Recognized
Innovative Biochips LLC has been selected as a finalist in Fierce Innovation Awards 2016 for its innovative product, Automated Yeast Aging Analysis System. - December 15, 2016 - Innovative Biochips
Gero LLC Attends the Bio International Convention 2016
Gero LLC, a leading drug development company, arranged a session at the Bio International Convention 2016 held at San Francisco from 6th-9th June. This event was first of its kind, since it focused on touching upon crucial topics such as combating the aging process, on a higher level. This yearly... - December 15, 2016 - PR Point
Bioscience Americas Lauds Passage of the 21st Century Cures Act
President Obama is expected to sign this landmark bi-partisan legislation soon. - December 13, 2016 - Bioscience Americas
The Cardiac & Vascular Institute Research Foundation to Participate in National Institutes of Health TACT2 Research Trial
Second study will focus on benefits of removing toxic metal pollutants in patients with diabetes and a prior heart attack. - December 07, 2016 - The Cardiac & Vascular Institute
Life Science Leader and ClinicalLeader.com Announce New Forum for Small to Mid-Sized Pharma and Biotech Companies
Life Science Leader and ClinicalLeader.com are excited to introduce Clinical Leader Forum, a new conference tailored just for executives at pharma and biotech sponsor companies that rely on contract research organizations for clinical trials. The inaugural event is scheduled for May 10 through 11... - December 07, 2016 - Clinical Leader Forum
New Research Explores Wearable Technology Utilization in Clinical Trials and the Role of CROs
New Report Identifies Current and Future Wearable Technology Utilization and CRO Implications with 130 Clinical Outsourcing Decision Makers. - December 01, 2016 - Life Science Strategy Group, LLC
MedLogiq Brings Acclaimed VAT® to Medical Devices
Proven solutions make medical devices safer, more reliable and improves time-to-market. Powerful technology solutions will be integrated with the General Infusion Pump (GIP) to assist in standardizing performance measurement, event monitoring and reporting. - November 30, 2016 - MedLogiq
Digital Health Startup Vitalistics Announces Public Launch
Vitalistics, a digital health startup transforming the overnight pulse oximetry and home sleep testing experience, launches today. - November 30, 2016 - Vitalistics
Telehealth Virtual Visits Market in US – Strategic Assessment and Forecast Till 2021
Analysts at Beige Market Intelligence predicts that the telehealth virtual visits market in US is expected to cross US$800 million in 2021 growing at a CAGR closed to 18%. - November 26, 2016 - Beige Market Intelligence
Partnering for Cures: Highlights from The Chauncey F. Lufkin III Foundation’s Participation at the Milken Institute’s FasterCures 2016 Partnering for Cures
The Chauncey F. Lufkin III Foundation was proud to participate in the Milken Institute’s annual Partnering for Cures Conference at The Grand Hyatt New York, held November 3-18, 2016. Partnering for Cures connects hundreds of decision-makers from across the medical research system who are... - November 23, 2016 - The Chauncey F. Lufkin III Foundation
Mount Sinai Beth Israel Receive Award from the Department of Defense to Study Gulf War Illness with electroCore’s Non-Invasive Vagus Nerve Stimulation Therapy
The Pain & Fatigue Study Center at Mount Sinai Beth Israel in New York has been awarded a United States Army Medical Research grant to conduct a study into the treatment of veterans of the 1990-1991 Gulf War who have Gulf War Illness using electroCore’s non-invasive vagus nerve... - November 17, 2016 - electroCore
Transnetyx Nears 12 Million Samples Genotyped, Gives 700 Working Years Back to Research
Transnetyx, an automated genotyping company, today announced that it will reach 12 million samples processed by the end of 2016. Since it began its operations in 2004, Transnetyx has served the research of more than 600 organizations – universities, hospitals and bioscience companies –... - November 16, 2016 - Transnetyx
New Gastrointestinal Pathogen Assays Available from ALPCO
ALPCO is now offering a line of research assays for the investigation of common bacterial and parasitic gastrointestinal (GI) pathogens including Giardia lamblia, Cryptosporidium spp., Blastocystis hominis, Entamoeba histolytica/dispar, and Clostridium difficile. These assays can be used to... - November 15, 2016 - ALPCO
New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1
ALPCO has released its new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA, the most sensitive active GLP-1 assay on the market. - November 09, 2016 - ALPCO
Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing
Dr. Leslie Miller backs the creation of a Registry of Cell Therapy to provide guidelines for stem cell use in therapies and treatments. - October 17, 2016 - Bioscience Americas
Gastric Cancer Foundation Event Promotes Research Funding to Improve Treatments and Save Lives - "A Cause for Hope" on November 18 in the San Francisco Bay Area
Stomach Cancer is the third leading cause of cancer deaths in the world, and is increasingly affecting young people. Yet only a tiny fraction of the nearly 1M gastric cancer sufferers worldwide have well-defined tumor mutations that can be addressed with current treatment options. To increase funding for the disease and encourage more researchers to focus on stomach cancer treatment, the Gastric Cancer Foundation will hold its Annual Event, A Cause for Hope, November 18 in the SF Bay Area. - October 17, 2016 - Gastric Cancer Foundation